Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Delivery of Intravenous Anti‐cancer Therapy at Home Versus in Hospital or Community Settings for Adults With Cancer." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus:_Cochrane_systematic_review. Accessed 25 April 2024.
Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus:_Cochrane_systematic_review. Accessed April 25, 2024.
Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus:_Cochrane_systematic_review
Delivery of Intravenous Anti‐cancer Therapy at Home Versus in Hospital or Community Settings for Adults With Cancer [Internet]. In: Cochrane Abstracts. [cited 2024 April 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Delivery of intravenous anti‐cancer therapy at home versus in hospital or community settings for adults with cancer
ID - 437811
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/437811/all/Melatonin_for_women_in_pregnancy_for_neuroprotection_of_the_fetus:_Cochrane_systematic_review
DB - Evidence Central
DP - Unbound Medicine
ER -